Liuwei Buqi Formula delays progression of chronic obstructive pulmonary disease in rats by regulating the NLRP3/caspase-1/GSDMD pyroptosis pathway

doi:10.12122/j.issn.1673-4254.2024.11.12

Abstract

Abstract:

Objective To explore the therapeutic mechanism of Liuwei Buqi (LWBQ) Formula for chronic obstructive pulmonary disease (COPD) in rat models. Methods SD rat models of COPD established by cigarette smoking combined with intratracheal lipopolysaccharide (LPS) instillation and hormone injection were treated with LWBQ Formula by gavage with or without intraperitoneal injection of MCC950 for 3 weeks, starting at the 5th week of modeling. After the treatments, the rats were examined for lung pathologies, lung function, total cell count and white blood cell count in bronchoalveolar lavage fluid (BALF), and serum levels of IL-6, TNF-α, IL-18 and NO. The mRNA expressions of NLRP3, ASC, caspase-1, GSDMD-N, IL-1β, and IL-18 in the lung tissue were detected with qRT-PCR. Results Compared with the normal control rats, the COPD rat models had severe lung pathologies and showed significantly decreased lung function, increased total cell and leukocyte subset counts in BALF, and increased serum levels of IL-6, TNF-α, IL-18 and NO and mRNA expressions of pyroptosis-related proteins in the lung tissue. Treatment of the rat models with LWBQ Formula significantly improved lung pathology and lung function, reduced total cell and leukocyte counts in BALF, and decreased serum levels of the inflammatory factors and expressions of pyroptosis-related proteins in the lung tissue. The combined treatment with MCC950 further improved lung pathology and function in spite of a significant difference, but BALF cell counts, serum inflammatory factor levels and pulmonary expressions of pyroptosis-related proteins were all significantly reduced following the treatment. Conclusion LWBQ Formula can delay the progression of COPD in rats possibly by inhibiting lung tissue pyroptosis via regulating the NLRP3/caspase-1/GSDMD pathway to reduce inflammatory response and lung damage.

Key words: Liuwei Buqi Formula, chronic obstructive pulmonary disease, NLRP3/caspase-1/GSDMD, pyroptosis, MCC950

Li MEI, Lu ZHANG, Di WU, Huanzhang DING, Xinru WANG, Xian ZHANG, Yuhang WEI, Zegeng LI, Jiabing TONG. Liuwei Buqi Formula delays progression of chronic obstructive pulmonary disease in rats by regulating the NLRP3/caspase-1/GSDMD pyroptosis pathway[J]. Journal of Southern Medical University, 2024, 44(11): 2156-2162.

Figures/Tables 7

Tab.1 Primer sequence

Gene	Primer sequences (5'-3')	Amplicon size(bp)
β-actin	CCCATCTATGAGGGTTACGC TTTAATGTCACGCACGATTTC	150
NLRP3	ATGCCGTATCTGGTTGTGTT GACTTAGGAAGAGCTGAGCA	142
ASC	GGCACAGCCAGAACAGAACATT TGTTTTGGTTGGGGGTCTCT	154
Caspase-1	AGCTTCAGTCAGGTCCATCAGC GGCAAAACTTGAGGGAACCAC	144
IL-1β	AGGCAGTGTCACTCATTGTGG TAGCAGGTCGTCATCATCCC	155
IL-18	TCAGACCACTTTGGCAGACT GAACACAGGCGGGTTTCTTT	96
GSDMD-N	TGAAGATCGTGGATCATGCC GGTAGAATTCCGAAGGCAGT	114

Fig.1 Comparison of lung function indexes among the groups. **P<0.01 vs control group, #P<0.05 vs model group.

Fig.2 Lung histopathological findings in each group (HE staining of rat lung tissue).

Fig.3 Giemsa staining of alveolar lavage fluid (BALF) (A) and leukocyte subset counts (B) in each group. **P<0.01 vs control group; ##P<0.01 vs model group; ΔP<0.05, ΔΔP<0.01 vs LWBQ group.

Fig.4 Comparison of serum inflammatory factors among the groups. **P<0.01 vs control group; ##P<0.01 vs model group; ΔP<0.05 vs LWBQ group.

Fig.5 Comparison of serum NO level among the groups. **P<0.01 vs control group; ##P<0.01 vs model group; ΔP<0.05 vs LWBQ group.

Fig.6 Comparison of mRNA expressions of pyroptosis-related proteins in the lung tissue among the groups. **P<0.01 vs Control group, ##P<0.01 vs model group; Δ P<0.05,ΔΔP<0.01 vs LWBQ group.

References 26

1	Venkatesan P. GOLD report: 2022 update[J]. Lancet Respir Med, 2022, 10(2): e20.
2	魏伟, 李玉叶. 慢性阻塞性肺疾病中医发病机制的研究进展[J]. 内蒙古中医药, 2021, 7(1): 162-3.
3	Liu CH, Chen Z, Chen K, et al. Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapy[J]. Cancer Res, 2021, 81(1): 144-57.
4	Tsai YM, Chiang KH, Hung JY, et al. Der f1 induces pyroptosis in human bronchial epithelia via the NLRP3 inflammasome[J]. Int J Mol Med, 2018, 41(2): 757-64.
5	Zhang CY, Zhu WJ, Meng QH, et al. Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis[J]. Ann Transl Med, 2022, 10(23): 1279.
6	Wang L, Lei W, Zhang SJ, et al. MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice[J]. Bioorg Med Chem, 2021, 30: 115954.
7	汪丹阳, 董昌武, 李泽庚, 等. 冬病夏治穴位敷贴配合六味补气颗粒治疗COPD稳定期疗效研究[J]. 辽宁中医药大学学报, 2019, 21(5): 87-90. DOI: 10.13194/j.issn.1673-842x.2019.05.022
8	张开宇, 吴同利, 刘欣欣, 等. 六味补气方联合常规治疗对慢性阻塞性肺疾病急性加重期的疗效研究[J]. 中国中医急症, 2016, 25(11): 2115-7.
9	童佳兵, 王心恒, 杨程, 等. 基于新安医学固本补气法综合干预COPD稳定期肺肾气虚证的临床观察研究[J]. 时珍国医国药, 2018, 29(6): 1372-4.
10	黄继汉, 黄晓晖, 陈志扬, 等. 药理试验中动物间和动物与人体间的等效剂量换算[J]. 中国临床药理学与治疗学, 2004, 9(9): 1069-72.
11	吴迪, 王小乐, 高雅婷, 等. 参芪温肺方减轻慢性阻塞性肺疾病大鼠的肺气虚证: 基于调节NLRP3/GSDMD细胞焦亡通路[J]. 南方医科大学学报, 2023, 43(9): 1500-8.
12	蔡治国. T细胞亚群及其相关因子在COPD肺、肾气虚证候模型大鼠中的差异性研究[D]. 济南: 山东中医药大学, 2008.
13	宋伟贤, 陈斯宁. 中医药干预慢性阻塞性肺疾病气道炎症及重塑的研究进展[J]. 中医药临床杂志, 2023, 9(1): 195-9.
14	曹庆伟, 杜鹃, 罗晋平, 等. 黄芪甲苷含量测定方法的优化及对不同产地、不同等级黄芪中黄芪甲苷含量分析[J]. 中国中药杂志, 2019, 44(13): 2813-9.
15	莫秀丽, 陈石生, 李涛, 等. 人参皂苷协同增效的研究进展[J]. 现代药物与临床, 2023, 38(12): 3174-80.
16	刘佳蕊, 崔天怡, 吕彬, 等. 玉竹的有效成分、药理活性及资源开发研究进展[J]. 食品与药品, 2023, 9(1): 135-9.
17	石峥. 益智仁乙酸乙酯部位的化学成分及白杨素的活性研究[D]. 成都: 西南交通大学, 2019.
18	侯小涛, 郝二伟, 秦健峰, 等. 肉桂的化学成分、药理作用及质量标志物(Q-marker)的预测分析[J]. 中草药, 2018, 49(1): 20-34.
19	Zhang Q, Song XX, Chen XM, et al. Antiosteoporotic effect of hesperidin against ovariectomy-induced osteoporosis in rats via reduction of oxidative stress and inflammation[J]. J Biochem Mol Toxicol, 2021, 35(8): e22832.
20	石炜弘, 窦丹波, 沈若冰. 诱导型一氧化氮合酶/一氧化氮在气道炎症中的研究进展[J]. 医学综述, 2022, 8(5): 852-7.
21	陈燕. 阳和平喘颗粒调控IKK/IκB/NF-κB信号通路防治支气管哮喘的机制研究[D].安徽中医药大学, 2023.
22	张孝侠, 吴友涛. 金雀异黄酮对慢性阻塞性肺疾病急性加重期模型大鼠肺组织炎症反应的影响[J]. 中国临床药理学杂志, 2023, 39(24): 3633-7.
23	陈新乐,张涛,黄淑君.嗜酸性粒细胞水平变化在COPD急性加重期患者病情评估中的应用价值[J].中国卫生工程学, 2023, 22(6): 826-7, 830.
24	Wang L, Meng J, Wang CC, et al. Hydrogen sulfide attenuates cigarette smoke-induced pyroptosis through the TLR4/NF‑κB signaling pathway[J]. Int J Mol Med, 2022, 49(5): 56.
25	Li J, An Z, Song J, et al. Fine particulate matter-induced lung inflammation is mediated by pyroptosis in mice[J]. Ecotoxicol Environ Saf, 2021, 219: 112351.
26	张俣, 王丽萍, 温春生, 等. 基于NLRP3信号通路探讨辛伐他汀抑制COPD大鼠肺组织细胞焦亡的作用研究[J]. 国际检验医学杂志, 2023, 44(11): 1305-10, 1316.

[1]	Haiyi ZHOU, Siyi HE, Ruifang HAN, Yongge GUAN, Lijuan DONG, Yang SONG. Moxibustion promotes endometrial repair in rats with thin endometrium by inhibiting the NLRP3/pyroptosis axis via upregulating miR-223-3p [J]. Journal of Southern Medical University, 2025, 45(7): 1380-1388.
[2]	Liming WANG, Hongrui CHEN, Yan DU, Peng ZHAO, Yujie WANG, Yange TIAN, Xinguang LIU, Jiansheng LI. Yiqi Zishen Formula ameliorates inflammation in mice with chronic obstructive pulmonary disease by inhibiting the PI3K/Akt/NF-κB signaling pathway [J]. Journal of Southern Medical University, 2025, 45(7): 1409-1422.
[3]	Lu ZHANG, Huanzhang DING, Haoran XU, Ke CHEN, Bowen XU, Qinjun YANG, Di WU, Jiabing TONG, Zegeng LI. Shenqi Buzhong Formula ameliorates mitochondrial dysfunction in a rat model of chronic obstructive pulmonary disease by activating the AMPK/SIRT1/PGC-1α pathway [J]. Journal of Southern Medical University, 2025, 45(5): 969-976.
[4]	Fenlan BIAN, Shiyao NI, Peng ZHAO, Maonanxing QI, Bi TANG, Hongju WANG, Pinfang KANG, Jinjun LIU. Asiaticoside alleviates myocardial ischemia-reperfusion injury in rats by inhibiting NLRP3 inflammasome-mediated pyroptosis [J]. Journal of Southern Medical University, 2025, 45(5): 977-985.
[5]	Yalei SUN, Meng LUO, Changsheng GUO, Jing GAO, Kaiqi SU, Lidian CHEN, Xiaodong FENG. Amentoflavone alleviates acute lung injury in mice by inhibiting cell pyroptosis [J]. Journal of Southern Medical University, 2025, 45(4): 692-701.
[6]	Zhengwang ZHU, Linlin WANG, Jinghan ZHAO, Ruixue MA, Yuchun YU, Qingchun CAI, Bing WANG, Pingsheng ZHU, Mingsan MIAO. Tuihuang Mixture improves α‑naphthylisothiocyanate-induced cholestasis in rats by inhibiting NLRP3 inflammasomes via regulating farnesoid X receptor [J]. Journal of Southern Medical University, 2025, 45(4): 718-724.
[7]	Ju HUANG, Lixia YIN, Minzhu NIU, Zhijun GENG, Lugen ZUO, Jing LI, Jianguo HU. Nodakenin ameliorates TNBS-induced experimental colitis in mice by inhibiting pyroptosis of intestinal epithelial cells [J]. Journal of Southern Medical University, 2025, 45(2): 261-268.
[8]	Huaiwen XU, Li WENG, Hong XUE. CXCL12 is a potential therapeutic target for type 2 diabetes mellitus complicated by chronic obstructive pulmonary disease [J]. Journal of Southern Medical University, 2025, 45(1): 100-109.
[9]	Yiming SUN, Rong ZHANG, Ying MENG, Lei ZHU, Mingqiang LI, Zhe LIU. Coenzyme Q10 alleviates depression-like behaviors in mice with chronic restraint stress by down-regulating the pyroptosis signaling pathway [J]. Journal of Southern Medical University, 2024, 44(5): 810-817.
[10]	FANG Shangping, SUN Renke, SU Hui, ZHAI Kecheng, XIANG Yu, GAO Yangmengna, GUO Wenjun. Chlorogenic acid alleviates acute kidney injury in septic mice by inhibiting NLRP3 inflammasomes and the caspase-1 canonical pyroptosis pathway [J]. Journal of Southern Medical University, 2024, 44(2): 317-323.
[11]	Duanyi SONG, Yun LI, Xuefang TANG, Hua LI, Kang TAO. Diazepam alleviates pulmonary fibrosis in mice by inhibiting LPS-induced pyroptosis and inflammation via the let-7a-5p/MYD88 axis [J]. Journal of Southern Medical University, 2024, 44(11): 2092-2101.
[12]	Ruoli DU, Qi YUN, Yiren WANG, Xinyu DOU, Hongwei YE, Jiahui WANG, Qin GAO. Plumbagin protect against sepsis-induced myocardial injury in mice by inhibiting the JAK2/STAT3 signaling pathway to reduce cardiomyocyte pyroptosis [J]. Journal of Southern Medical University, 2024, 44(11): 2209-2219.
[13]	Ping SHU, Mengke YUAN, Ke YANG, Weizhi HE, Li LIU. Quercetin suppresses pyroptosis in mouse fibroblasts by inhibiting the NLRP3/caspase-1/GSDMD pathway [J]. Journal of Southern Medical University, 2024, 44(10): 1874-1880.
[14]	Qinjun YANG, Hui WANG, Shuyu XU, Cheng YANG, Huanzhang DING, Di WU, Jie ZHU, Jiabing TONG, Zegeng LI. Shenqi Tiaoshen Formula alleviates airway inflammation in rats with chronic obstructive pulmonary disease and kidney qi deficiency syndrome by inhibiting ferroptosis via regulating the Nrf2/SLC7A11/GPX4 signaling pathway [J]. Journal of Southern Medical University, 2024, 44(10): 1937-1946.
[15]	Mengmeng CHENG, Xinguang LIU, Yanxin WEI, Xiaoxiang XING, Lan LIU, Nan XIN, Peng ZHAO. Tongsai Granules inhibit autophagy and macrophage-mediated inflammatory response to improve acute exacerbations of chronic obstructive pulmonary disease in rats [J]. Journal of Southern Medical University, 2024, 44(10): 1995-2003.